Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

11 clinical studies listed.

Filters:

Growth

Tundra lists 11 Growth clinical trials. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.

This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.

NOT YET RECRUITING

NCT07513506

Extensively Hydrolyzed Formula Growth Monitioring Study (GMS)

This is a research study to compare an investigational infant formula against a currently marketed infant formula. An investigational infant formula is one that has never been approved by the United States Food and Drug Administration (FDA). The purpose of this research study is to evaluate the growth and tolerance of infants who consume a new (not yet available to buy) extensively hydrolyzed cow milk protein infant formula compared to an extensively hydrolyzed cow milk protein infant formula that is currently available to buy. The study will also look at the growth of your baby, how many poops your baby has, what the poops are like (for example, soft or hard), how much study formula your baby drinks, how well your baby handles the study formula (such as spit-up, fussiness, gas, colic, or changes in sleep), and any health problems that might come up during the study.

Gender: All

Ages: 10 Days - 14 Days

Updated: 2026-04-07

9 states

Growth
RECRUITING

NCT07514182

Improving Artificial Intelligence-derived Algorithms for Estimating Length and Weight in NEonateS and infanTs up to 6 Months of Age (NEST)

The NEST study is a prospective, observational research study designed to collect clinical measurements and image data to develop and evaluate artificial intelligence (AI)-derived algorithms for estimating anthropometric parameters in neonates and young infants. The study focuses on infants from birth up to 6 months of age and aims to assess the accuracy of AI-based estimations of length, weight, and head circumference using photographs and/or video recordings captured during routine clinical care. These AI-derived measurements will be compared against standard clinical measurements obtained by trained healthcare professionals in neonatal and infant care settings.

Gender: All

Ages: 0 Days - 6 Months

Updated: 2026-04-07

Growth
Neonates
AI (Artificial Intelligence)
NOT YET RECRUITING

NCT07409038

Growth and Feeding Tolerance in Premature Infants

The main purpose of the study is to evaluate the effect of early human milk fortification versus delayed fortification on growth and feeding tolerance in premature infants.

Gender: All

Ages: 28 Weeks - 31 Weeks

Updated: 2026-02-13

1 state

Feeding Tolerance
Growth
ACTIVE NOT RECRUITING

NCT06137235

Effects of an Infant Formula and follow-on Formula Containing Bio-active Ingredients on Growth, Tolerance and Infections

In this clinical trial, the growth (weight for age), product tolerance (product intake, comfort) and infection-related symptoms of healthy infants consuming an IF and FOF containing bio-active ingredients will be evaluated and compared to a group of infants consuming a standard IF and FOF.

Gender: All

Ages: 5 Days - 60 Days

Updated: 2026-01-29

Growth
Infections
RECRUITING

NCT06018636

Impact of Diet and Nutrition on Growth and Development in Young Children

The association between nutrition in early life and its long-term health consequences has long been known. However, there is a scarcity of scientific evidence on how nutritional status affects child growth and development in remote, rural agro-pastoral communities with distinct dietary intake habits, geographical location, socio-economic status, and cultures.

Gender: All

Ages: 1 Day - 24 Months

Updated: 2026-01-08

1 state

Nutrition
Growth
Development
+4
NOT YET RECRUITING

NCT07312201

Oral Nutritional Supplementation in Children With Growth Concerns

Multi-center, single-blinded, randomized, controlled study consisting of two arms, to investigate the impact of an oral nutritional supplement in combination with dietary counseling on growth in children with growth concerns as compared to children who receive dietary counselling alone

Gender: All

Ages: 24 Months - 41 Months

Updated: 2025-12-31

Growth
Toddlers
Attention
+1
NOT YET RECRUITING

NCT07292636

The Effectiveness of the Twin Block and Carriere Motion Appliances in Post-pubertal Patients and an Evaluation of the Impact of Class II Malocclusion and Its Correction on Oral Health-related Quality of Life

The investigators of this clinical trial aim to: * Compare the effectiveness and efficiency of Clark's Twin Block Appliance (CTB) vs Carriere Motion Appliance (CMA) in correcting Class II malocclusion when used in post-pubertal older adolescents, in terms of skeletal and dental change. * Evaluate potential negative oral health-related quality of life (OHRQoL) impacts during the active treatment phase with either CTB or CMA in post-pubertal adolescents. * Investigate the impact of Class II malocclusion on oral health-related quality of life (OHRQoL) in post-pubertal adolescents. Class II division 1 malocclusion is a dental condition where the upper teeth protrude significantly over the lower teeth. It is a common type of malocclusion observed in orthodontic practice, accounting for approximately 20-25% globally. Correcting Class II malocclusion in growing patients using functional appliances and Class II correctors is relatively predictable. In Ireland and the United Kingdom, the Clark's Twin Block (CTB) is the most commonly used functional appliance. The CTB consists of two components: one for the upper teeth and one for the lower teeth. These components are engineered to position the lower jaw forward, thereby promoting the desired dentoskeletal changes (moving the upper teeth back and lower forward). Another device used for Class II correction is the Carriere Motion Appliance (CMA). The CMA is gaining popularity as a treatment option for Class II malocclusion, inducing dental changes similar to those achieved with a CTB. However, uncertainty persists regarding the effectiveness of these appliances in older adolescents in the post-pubertal growth phase (aged approximately 14.5 years or above). Additionally, although both CTB and CMA are effective in growing patients in correcting dental and skeletal discrepancies, they may influence daily activities, comfort, and psychological aspects, which often results in poor compliance. Poor adherence to orthodontic treatment, whether with fixed or removable appliances, can lead to higher rates of treatment failure.

Gender: All

Ages: 14 Years - Any

Updated: 2025-12-18

1 state

CLASS II DIVISION 1 MALOCCLUSION
Class II Malocclusion
Growth
+5
ACTIVE NOT RECRUITING

NCT03003117

The prEgnanCy and eArly Childhood nutrItion triaL (ECAIL)

The purpose of this study is to conduct a randomized controlled trial among 800 socially disadvantaged pregnant women and their families to test the effectiveness of a multi-component home visitation nutrition program, compared to usual care, in promoting healthy feeding practices, lifestyle behaviors and growth in young children.

Gender: FEMALE

Ages: 18 Years - Any

Updated: 2025-12-01

Diet
Growth
Infant
+2
ACTIVE NOT RECRUITING

NCT06744699

Assessment of Gastrointestinal Discomfort and Infections in Healthy Term Infants

A retrospective observational medical dossier-based study to assess gastrointestinal discomfort and infections in healthy term infants

Gender: All

Ages: Any - 24 Months

Updated: 2024-12-20

Gastrointestinal Symptoms
Infection
Allergy Symptoms
+1
NOT YET RECRUITING

NCT05551975

Preterm Infants Fed a Human Milk Fortifier

This is a double-blind, randomized, multi-center, controlled, parallel study to evaluate the growth and tolerance of preterm infants fed human milk fortifier (HMF).

Gender: All

Updated: 2024-06-28

11 states

Growth
NOT YET RECRUITING

NCT05117164

Enteral Feeding in Infants With Duct Dependant Lesions.

This is a multicenter randomised controlled trial to assess whether standardised enteral feeding in newborns with duct dependenty congenital heart disease decreases the risk of necrotising enterocolitis (NEC). The investigators plan to include a total 384 infants. The study will be carried out in three level III hospitals in Poland. The primary end will be NEC and/or death. Secondary end points include weight gain, hospital length of stay, time required to reach full feeding.

Gender: All

Ages: 1 Minute - 72 Hours

Updated: 2022-07-20

Duct Dependent Lesions
Necrotising Enterocolitis
Death
+1